洞察市场格局
解锁药品研发情报

400客服电话

  • 购买数据产品

    400-9696-311 转1

  • 定制咨询业务

    400-9696-311 转2

  • 数据与AI定制业务

    400-9696-311 转3

  • 商务合作及其他问题

    400-9696-311 转4

  • 投诉及建议

    400-9696-311 转5

医药数据查询

【ChiCTR1800019706】Effects of a Multimedia Educational Programme for Children with Asthma or Recurrent Wheeze: A Randomized Controlled Trial

基本信息
登记号

ChiCTR1800019706

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2018-11-24

临床申请受理号

/

靶点

/

适应症

兒童哮喘

试验通俗题目

Effects of a Multimedia Educational Programme for Children with Asthma or Recurrent Wheeze: A Randomized Controlled Trial

试验专业题目

Effects of a Multimedia Educational Programme for Children with Asthma or Recurrent Wheeze: A Randomized Controlled Trial

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

1. To determine the effectiveness of the multimedia education programme on improving asthma childrens health outcomes; 2. To determine the effectiveness of the multimedia education programme on enhancing parents KAP on asthma.

试验分类
请登录查看
试验类型

随机平行对照

试验分期

卫生服务研究

随机化

The potential participants will be randomly allocated to either the intervention or control group in equal probability to reduce the bias on this new method of intervention. Group assignments will be placed in sealed, opaque and identical envelopes at a randomised order to maintain the allocation concealment.

盲法

Single blind

试验项目经费来源

NA

试验范围

/

目标入组人数

56

实际入组人数

/

第一例入组时间

2018-12-01

试验终止时间

2019-09-30

是否属于一致性

/

入选标准

Children: 1. A child between 4–11 years old; 2.A child admitted for asthma (ICD-10) or recurrent wheezing (more than two episodes in the last year) regardless if the diagnosis is initial or recurrent. Parent: 1. Parent with a child between 4 and 11 years old who is admitted for asthma or wheezing attack during the study period.;

排除标准

Children: 1. Chronic lung disease, such as bronchopulmonary dysplasia, which will confound the lung function assessment; 2. Developmental delay; 3. Cannot communicate in Cantonese and understand Chinese; 4. Participation in similar study; This study will exclude children aged 0 to 3 years old because making a certain diagnosis of asthma is difficult for young children given that wheezing or cough symptoms are common even for those who do not have asthma (Pedersen et al., 2011). Furthermore, adolescents (aged 12 to 17 years old) pose significant differences in cognitive ability compared with young children. They will have different delivery approaches to health education. Thus, children aged 12 to 17 years old will also be excluded from this study to decrease the confounding variables including level of anxiety, asthma control or medication adherence. Parent: 1. Cannot communicate in Cantonese and understand Chinese; 2. Has no smartphone; 3. Participation in similar study.;

研究者信息
研究负责人姓名
请登录查看
试验机构

基督教聯合醫院

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用

全球药物研发中心
全球研发数据与行业前沿情报

383,318
全球在研药物数
964
本月临床试验数
全球批准的新药
更多
全球首批
各国首批
数据来源:摩熵医药
更新时间:
研发动态
相关报告
政策法规
更多信息,请进入全球药物研发中心查看

医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测

2,630亿元
2026年Q2总销售额
6.14%(2026Q2)
TOP5企业市场份额
药品销售排行榜
查看完整数据
2025Q4医院化学药销售增速 *按市场份额排序
  • 1
    甲氨蝶呤注射液
  • 2
    克霉唑阴道乳膏
  • 3
    氯化钠注射液
核心能力
  • 医药市场销售数据分析 · 医院、实体药店、网上药店
  • 市场竞争格局分析(靶点、药品类型、ATC大类)
更多信息,请进入医药市场洞察中心查看